Ambulatory emergency oncology: A key tenet of future emergency oncology care.
MASCC
ambulatory care
emergency oncology
febrile neutropenia
incidental pulmonary embolism
Journal
International journal of clinical practice
ISSN: 1742-1241
Titre abrégé: Int J Clin Pract
Pays: India
ID NLM: 9712381
Informations de publication
Date de publication:
Jan 2020
Jan 2020
Historique:
received:
02
07
2019
revised:
16
09
2019
accepted:
13
10
2019
pubmed:
22
10
2019
medline:
26
8
2020
entrez:
22
10
2019
Statut:
ppublish
Résumé
Ambulatory emergency oncology The challenges of emergency oncology alongside its increasing financial burden have led to an interest in developing optimal care models for meeting patients' needs. Ambulatory care is recognised as a key tenet in ensuring the safety and sustainability of acute care services. Increased access to ambulatory care has successfully reduced ED utilisation and improved clinical outcomes in high-risk non-oncological populations. Individualised management of acute cancer presentations is a key challenge for emergency oncology services so that it can mirror routine cancer care. There are an increasing number of acute cancer presentations, such as low-risk febrile neutropenia and incidental pulmonary embolism, that can be risk assessed for care in an emergency ambulatory setting. Modelling of ambulatory emergency oncology services will be dependent on local service deliveries and pathways, but are key for providing high quality, personalised and sustainable emergency oncology care. These services will also be at the forefront of much needed emergency oncology to define the optimal management of ambulatory-sensitive presentations.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e13436Informations de copyright
© 2019 John Wiley & Sons Ltd.
Références
Rivera D, Gallicchio L, Brown J, et al. Trends in adult cancer-related Emergency Department utilisation. JAMA Oncol. 2017;3:e172450.
Brown J, Grudzen C, Kyriacou DN, et al. The emergency care of patients with cancer: setting the research agenda. Ann Emerg Med. 2016;68:706-711.
Cooksley T, Rice T. Emergency oncology: development, current position and future direction in the US and UK. Support Care Cancer. 2017;25:3-7.
Lasserson DS, Harris C, Elias T, et al. What is the evidence base for ambulatory care for acute medical illness? Acute Med. 2018;17:148-153.
Todd KH, Thomas CR Jr. An inflection point in the evolution of oncologic emergency medicine. Ann Emerg Med. 2016;68:712-716.
Hamad M, Connolly V. Ambulatory emergency care - improvement by design. Clin Med. 2018;18:69-74.
Conley J, O’Brien CW, Leff BA, et al. Alternative strategies to inpatient hospitalization for inpatient conditions: a systematic review. JAMA Intern Med. 2016;176:1693-1702.
Bischof JJ, Sellers JB, Phillips AW, Petrongelli JJ, Stuckey AE, Platts-Mills TF. Patient navigation for complex care patients in the emergency department: a survey of oncology patient navigators. Support Care Cancer. 2019;27:4359-4362.
Klastersky J, Paesmans M, Rubenstein EB, et al. The multinational association for supportive care in cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Onc. 2000;18:3038-3051.
Carmona-Bayonas A, Jiménez-Fonseca P, Virizuela Echaburu J, et al. Prediction of serious complications in patients with seemingly stable febrile neutropenia: validation of the clinical index of stable febrile neutropenia in a prospective cohort of patients from the FINITE study. J Clin Onc. 2015;33:465-471.
Klastersky J, Paesmans M. The Multinational Association for Supportive Care in Cancer (MASCC) risk score: 10 years of use for identifying low risk neutropenic cancer patients. Support Care Cancer. 2013;21:1487-1495.
Knight T, Ahn S, Rice TW, Cooksley T. Acute oncology care: a narrative review of the acute management of neutropenic sepsis and immune-related toxicities of checkpoint inhibitors. Eur J Intern Med. 2017;45:59-65.
Cooksley T, Holland M, Klastersky J. Ambulatory outpatient management of patients with low risk febrile neutropaenia. Acute Med. 2015;14:178-181.
Howard LS, Barden S, Condliffe R, et al. British thoracic society guideline for in the initial outpatient management of pulmonary embolism. Thorax. 2018;73(Suppl 2):ii1-ii29.
Reschen ME, Raby J, Bowen J, Singh S, Lasserson D, O'Callaghan CA. A retrospective analysis of outcomes in low- and intermediate-high-risk pulmonary embolism patients managed on an ambulatory medical unit in the UK. ERJ Open Res. 2019;5:00184-2018.
Banala SR, Yeung S-C, Rice TW, et al. Discharge or admit? Emergency department management of incidental pulmonary embolism in patients with cancer: a retrospective study. Int J Emerg Med. 2017;10:19.
Ahn S, Cooksley T, Banala S, Buffardi L, Rice TW. Validation of the EPIPHANY index for predicting risk of serious complications in cancer patients with incidental pulmonary embolism. Support Care Cancer. 2018;26:3601-3607.
Caterino J, Adler D, Durham D. Analysis of diagnosis, symptoms, medications and admissions among patients with cancer presenting to Emergency Departments. JAMA Netw Open. 2019;2:e190979.
El Majzoub I, Qdaisat A, Thein KZ, et al. Adverse effects of immune checkpoint therapy in cancer patients visiting the Emergency Department of a comprehensive cancer center. Ann Emerg Med. 2019;73:79-87.
Champiat S, Lambotte O, Barreau E, et al. Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper. Ann Oncol. 2016;27:559-574.
Webb P, Rice TW, Cooksley T. Immune-mediated complications of checkpoint inhibitors for the acute physician. Acute Med. 2017;16:21-24.
Marshall E. Ambulatory management in low risk neutropenic sepsis - a plea for integrated acute cancer care. Acute Med. 2019;18:5-6.
Hui D, Bruera E. Integrating palliative care into the trajectory of cancer care. Nat Rev Clin Oncol. 2016;13:159-171.
Cooksley T, Campbell G, Al-Sayed T, Lamola L, Berman R. A novel approach to improving ambulatory outpatient management of low risk febrile neutropenia: an Enhanced Supportive Care (ESC) Clinic. Support Care Cancer. 2018;26:2937-2940.
Lipitz-Snyderman A, Klotz A, Atoria CL, Martin S, Groeger J. Impact of observation status on hospital use for patients with cancer. J Oncol Pract. 2015;11:73-77.
Teh BW, Brown C, Joyce T, et al. Safety and cost of an ambulatory program for patients with low-risk neutropenic fever at an Australian centre. Support Care Cancer. 2018;26:997-1003.
Adler D, Abar B, Durham D, et al. Validation of the emergency severity index for the triage of adult Emergency Department patients with active cancer. J Emerg Med. 2019;57:354-361.